Aerie pharmaceuticals to participate in upcoming investor conferences

Durham, n.c.--(business wire)--aerie pharmaceuticals, inc. (nasdaq: aeri), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that the vicente anido, jr., ph.d., chairman and chief executive officer, will participate in the following virtual investor conferences. citi 16th annual biopharma conference date:
AERI Ratings Summary
AERI Quant Ranking